Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 544

1.

A review of changes to the attention deficit/hyperactivity disorder age of onset criterion using the checklist for modifying disease definitions.

Sanders S, Thomas R, Glasziou P, Doust J.

BMC Psychiatry. 2019 Nov 12;19(1):357. doi: 10.1186/s12888-019-2337-7.

PMID:
31718626
2.

Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis.

Scott AM, Stehlik P, Clark J, Zhang D, Yang Z, Hoffmann T, Mar CD, Glasziou P.

Ann Fam Med. 2019 Nov;17(6):545-553. doi: 10.1370/afm.2445. Review.

3.

Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.

Bach AC, Lo KS, Pathirana T, Glasziou PP, Barratt AL, Jones MA, Bell KJ.

Med J Aust. 2019 Nov 6. doi: 10.5694/mja2.50376. [Epub ahead of print]

PMID:
31691294
4.

Is the NHS 'Heart Age Test' too much medicine?

Bonner C, McKinn S, McCaffrey K, Glasziou P, Irwig L, Doust J, Jansen J, Bell K.

Br J Gen Pract. 2019 Oct 31;69(688):560-561. doi: 10.3399/bjgp19X706349. Print 2019 Nov. No abstract available.

PMID:
31672817
5.

Reducing research waste by promoting informed responses to invitations to participate in clinical trials.

Gillies K, Chalmers I, Glasziou P, Elbourne D, Elliott J, Treweek S.

Trials. 2019 Oct 28;20(1):613. doi: 10.1186/s13063-019-3704-x.

6.

Efficacy of habit-based weight loss interventions: a systematic review and meta-analysis.

Cleo G, Beller E, Glasziou P, Isenring E, Thomas R.

J Behav Med. 2019 Sep 16. doi: 10.1007/s10865-019-00100-w. [Epub ahead of print] Review.

PMID:
31529279
7.

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.

Razavi M, Glasziou P, Klocksieben FA, Ioannidis JPA, Chalmers I, Djulbegovic B.

JAMA Netw Open. 2019 Sep 4;2(9):e1911111. doi: 10.1001/jamanetworkopen.2019.11111.

8.

Development of a contemporary evidence-based practice workshop for health professionals with a focus on pre-appraised evidence and shared decision-making: a before-after pilot study.

Albarqouni L, Glasziou P, Bakhit M, Del Mar C, Hoffmann TC.

BMJ Evid Based Med. 2019 Aug 30. pii: bmjebm-2019-111220. doi: 10.1136/bmjebm-2019-111220. [Epub ahead of print]

PMID:
31471315
9.

The importance of randomised vs non-randomised trials.

Djulbegovic B, Glasziou P, Chalmers I.

Lancet. 2019 Aug 24;394(10199):634-635. doi: 10.1016/S0140-6736(19)31128-6. No abstract available.

PMID:
31448731
10.

Promoting critical appraisal skills.

Elessi K, Albarqouni L, Glasziou P, Chalmers I.

Lancet. 2019 Jun 29;393(10191):2589-2590. doi: 10.1016/S0140-6736(19)30346-0. Epub 2019 Jun 27. No abstract available.

PMID:
31258125
11.

Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.

Thomas ET, Guppy M, Straus SE, Bell KJL, Glasziou P.

BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150.

12.

A question of trust: can we build an evidence base to gain trust in systematic review automation technologies?

O'Connor AM, Tsafnat G, Thomas J, Glasziou P, Gilbert SB, Hutton B.

Syst Rev. 2019 Jun 18;8(1):143. doi: 10.1186/s13643-019-1062-0.

13.

Overdiagnosis in respiratory medicine.

Dobler CC, Glasziou PP.

Respirology. 2019 Oct;24(10):939-941. doi: 10.1111/resp.13623. Epub 2019 Jun 17. No abstract available.

14.

Current Knowledge and Adoption of Mobile Health Apps Among Australian General Practitioners: Survey Study.

Byambasuren O, Beller E, Glasziou P.

JMIR Mhealth Uhealth. 2019 Jun 3;7(6):e13199. doi: 10.2196/13199.

15.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Glasziou PP.

Med J Aust. 2019 Jun;210(11):525-525.e1. doi: 10.5694/mja2.50197. Epub 2019 May 22. No abstract available.

PMID:
31119741
16.

Use of the terms "overdiagnosis" and "misdiagnosis" in the COPD literature: a rapid review.

Thomas ET, Glasziou P, Dobler CC.

Breathe (Sheff). 2019 Mar;15(1):e8-e19. doi: 10.1183/20734735.0354-2018.

17.

Reforming disease definitions: a new primary care led, people-centred approach.

Moynihan R, Brodersen J, Heath I, Johansson M, Kuehlein T, Minué-Lorenzo S, Petursson H, Pizzanelli M, Reventlow S, Sigurdsson J, Stavdal A, Treadwell J, Glasziou P.

BMJ Evid Based Med. 2019 Oct;24(5):170-173. doi: 10.1136/bmjebm-2018-111148. Epub 2019 Apr 8. No abstract available.

PMID:
30962252
18.

The number needed to treat in pairwise and network meta-analysis and its graphical representation.

Veroniki AA, Bender R, Glasziou P, Straus SE, Tricco AC.

J Clin Epidemiol. 2019 Jul;111:11-22. doi: 10.1016/j.jclinepi.2019.03.007. Epub 2019 Mar 21.

PMID:
30905696
19.
20.

Authors' reply to Sharp and Curlewis, Ahmed and colleagues, and Sreeharan.

Glasziou P, Chalmers I.

BMJ. 2019 Mar 8;364:l808. doi: 10.1136/bmj.l808. No abstract available.

PMID:
30850382
21.
22.

Still moving toward automation of the systematic review process: a summary of discussions at the third meeting of the International Collaboration for Automation of Systematic Reviews (ICASR).

O'Connor AM, Tsafnat G, Gilbert SB, Thayer KA, Shemilt I, Thomas J, Glasziou P, Wolfe MS.

Syst Rev. 2019 Feb 20;8(1):57. doi: 10.1186/s13643-019-0975-y.

23.

The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018.

Chalmers I, Atkinson P, Badenoch D, Glasziou P, Austvoll-Dahlgren A, Oxman A, Clarke M.

Res Involv Engagem. 2019 Feb 4;5:6. doi: 10.1186/s40900-019-0138-2. eCollection 2019.

24.

GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.

Schünemann HJ, Mustafa RA, Brozek J, Santesso N, Bossuyt PM, Steingart KR, Leeflang M, Lange S, Trenti T, Langendam M, Scholten R, Hooft L, Murad MH, Jaeschke R, Rutjes A, Singh J, Helfand M, Glasziou P, Arevalo-Rodriguez I, Akl EA, Deeks JJ, Guyatt GH; GRADE Working Group.

J Clin Epidemiol. 2019 Jul;111:69-82. doi: 10.1016/j.jclinepi.2019.02.003. Epub 2019 Feb 7.

PMID:
30738926
25.

Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?

Bell KJL, Doust J, Glasziou P, Cullen L, Harris IA, Smith L, Buchbinder R, Barratt A.

Ann Intern Med. 2019 Feb 19;170(4):259-261. doi: 10.7326/M18-2645. Epub 2019 Feb 5. No abstract available.

PMID:
30716768
26.

An Australian community jury to consider case-finding for dementia: Differences between informed community preferences and general practice guidelines.

Thomas R, Sims R, Beller E, Scott AM, Doust J, Le Couteur D, Pond D, Loy C, Forlini C, Glasziou P.

Health Expect. 2019 Jun;22(3):475-484. doi: 10.1111/hex.12871. Epub 2019 Feb 3.

27.

A truly 'HANDI' resource.

Simon C, Glasziou P.

Br J Gen Pract. 2019 Feb;69(679):80-81. doi: 10.3399/bjgp19X701057. No abstract available.

PMID:
30705007
28.

External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.

Albarqouni L, Doust JA, Magliano D, Barr EL, Shaw JE, Glasziou PP.

Med J Aust. 2019 Mar;210(4):161-167. doi: 10.5694/mja2.12061. Epub 2019 Jan 18.

PMID:
30656697
29.

Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Hansen MP, Scott AM, McCullough A, Thorning S, Aronson JK, Beller EM, Glasziou PP, Hoffmann TC, Clark J, Del Mar CB.

Cochrane Database Syst Rev. 2019 Jan 18;1:CD011825. doi: 10.1002/14651858.CD011825.pub2.

PMID:
30656650
30.

Core Competencies in Evidence-Based Practice for Health Professionals: Consensus Statement Based on a Systematic Review and Delphi Survey.

Albarqouni L, Hoffmann T, Straus S, Olsen NR, Young T, Ilic D, Shaneyfelt T, Haynes RB, Guyatt G, Glasziou P.

JAMA Netw Open. 2018 Jun 1;1(2):e180281. doi: 10.1001/jamanetworkopen.2018.0281.

PMID:
30646073
31.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

32.

Australia is responding to the complex challenge of overdiagnosis.

Moynihan R, Barratt AL, Buchbinder R, Carter SM, Dakin T, Donovan J, Elshaug AG, Glasziou PP, Maher CG, McCaffery KJ, Scott IA.

Med J Aust. 2018 Oct 15;209(8):332-334. No abstract available.

PMID:
30309305
33.

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.

Nayak A, Hayen A, Zhu L, McGeechan K, Glasziou P, Irwig L, Doust J, Gregory G, Bell K.

BMJ Open. 2018 Oct 4;8(9):e020584. doi: 10.1136/bmjopen-2017-020584.

34.

Sustaining knowledge translation interventions for chronic disease management in older adults: protocol for a systematic review and network meta-analysis.

Tricco AC, Moore JE, Beben N, Brownson RC, Chambers DA, Dolovich LR, Edwards A, Fairclough L, Glasziou PP, Graham ID, Hemmelgarn BR, Holmes B, Isaranuwatchai W, Lachance CC, Legare F, McGowan J, Majumdar SR, Presseau J, Squires JE, Stelfox HT, Strifler L, Thompson K, Van der Weijden T, Veroniki AA, Straus SE.

Syst Rev. 2018 Sep 15;7(1):140. doi: 10.1186/s13643-018-0808-4.

35.

A brief history of clinical evidence updates and bibliographic databases.

Glasziou P, Aronson JK.

J R Soc Med. 2018 Aug;111(8):292-301. doi: 10.1177/0141076818788819. No abstract available.

PMID:
30102098
36.

Evidence-based practice educational intervention studies: a systematic review of what is taught and how it is measured.

Albarqouni L, Hoffmann T, Glasziou P.

BMC Med Educ. 2018 Aug 1;18(1):177. doi: 10.1186/s12909-018-1284-1. Review.

37.

Why Cochrane should prioritise sharing data.

Shokraneh F, Adams CE, Clarke M, Amato L, Bastian H, Beller E, Brassey J, Buchbinder R, Davoli M, Del Mar C, Glasziou P, Gluud C, Heneghan C, Hoffmann T, Ioannidis JP, Jayaram M, Kwong J, Moher D, Ota E, Sheriff RS, Vale L, Goldacre B.

BMJ. 2018 Jul 30;362:k3229. doi: 10.1136/bmj.k3229. No abstract available. Erratum in: BMJ. 2018 Aug 15;362:k3542.

PMID:
30061322
38.

Statistical power of clinical trials increased while effect size remained stable: an empirical analysis of 136,212 clinical trials between 1975 and 2014.

Lamberink HJ, Otte WM, Sinke MRT, Lakens D, Glasziou PP, Tijdink JK, Vinkers CH.

J Clin Epidemiol. 2018 Oct;102:123-128. doi: 10.1016/j.jclinepi.2018.06.014. Epub 2018 Jul 5.

PMID:
29981870
39.

Deliberate clinical inertia: Using meta-cognition to improve decision-making.

Keijzers G, Fatovich DM, Egerton-Warburton D, Cullen L, Scott IA, Glasziou P, Croskerry P.

Emerg Med Australas. 2018 Aug;30(4):585-590. doi: 10.1111/1742-6723.13126. Epub 2018 Jul 2.

PMID:
29963756
40.

Making progress with the automation of systematic reviews: principles of the International Collaboration for the Automation of Systematic Reviews (ICASR).

Beller E, Clark J, Tsafnat G, Adams C, Diehl H, Lund H, Ouzzani M, Thayer K, Thomas J, Turner T, Xia J, Robinson K, Glasziou P; founding members of the ICASR group.

Syst Rev. 2018 May 19;7(1):77. doi: 10.1186/s13643-018-0740-7.

41.

Prescribable mHealth apps identified from an overview of systematic reviews.

Byambasuren O, Sanders S, Beller E, Glasziou P.

NPJ Digit Med. 2018 May 9;1:12. doi: 10.1038/s41746-018-0021-9. eCollection 2018. Review.

42.

Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.

Bell KJL, Doust J, Glasziou P.

JAMA Intern Med. 2018 Jun 1;178(6):755-757. doi: 10.1001/jamainternmed.2018.0310. No abstract available.

PMID:
29710197
43.

Automated screening of research studies for systematic reviews using study characteristics.

Tsafnat G, Glasziou P, Karystianis G, Coiera E.

Syst Rev. 2018 Apr 25;7(1):64. doi: 10.1186/s13643-018-0724-7.

44.

Habit-based interventions for weight loss maintenance in adults with overweight and obesity: a randomized controlled trial.

Cleo G, Glasziou P, Beller E, Isenring E, Thomas R.

Int J Obes (Lond). 2019 Feb;43(2):374-383. doi: 10.1038/s41366-018-0067-4. Epub 2018 Apr 23.

PMID:
29686382
45.

Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review.

Scott AM, Beller E, Glasziou P, Clark J, Ranakusuma RW, Byambasuren O, Bakhit M, Page SW, Trott D, Mar CD.

Int J Antimicrob Agents. 2018 Sep;52(3):316-323. doi: 10.1016/j.ijantimicag.2018.04.005. Epub 2018 Apr 13.

PMID:
29660406
46.

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration.

PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar.

47.

The importance and challenges of shared decision making in older people with multimorbidity.

Hoffmann T, Jansen J, Glasziou P.

PLoS Med. 2018 Mar 13;15(3):e1002530. doi: 10.1371/journal.pmed.1002530. eCollection 2018 Mar.

48.

High-Sensitivity Troponin Highlights the Need for New Methods to Evaluate Diagnostic Tests.

Doust J, Glasziou P.

Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004468. doi: 10.1161/CIRCOUTCOMES.117.004468. No abstract available.

PMID:
29444927
49.

Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval.

Djulbegovic B, Glasziou P, Klocksieben FA, Reljic T, VanDenBergh M, Mhaskar R, Ioannidis JPA, Chalmers I.

J Clin Epidemiol. 2018 Jun;98:24-32. doi: 10.1016/j.jclinepi.2018.01.011. Epub 2018 Feb 10. Review.

PMID:
29432860
50.

Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?

Bonner C, Bell K, Jansen J, Glasziou P, Irwig L, Doust J, McCaffery K.

BMC Cardiovasc Disord. 2018 Feb 7;18(1):19. doi: 10.1186/s12872-018-0760-1.

Supplemental Content

Loading ...
Support Center